Doctors at Baylor College of Medicine have confirmed that the use of the portable Organ Care System (OCS), or "breathing lung" technology, boosts long-term survival for transplant patients. This ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that it will present ...

About a third of lung transplant patients with cystic fibrosis receive elexacaftor-tezacaftor-ivacaftor; use is higher among ...

Organ transplants not only save lives, they transform them. For our vital organs like hearts and lungs the impact of a ...

Milestone in the field of lung transplantation: Improvement in rejection and infection rate thanks to extracorporeal photopheresis Findings could significantly change the standard procedure for ...

After lung transplantation, infection with Pseudomonas aeruginosa independently predicted antibody-mediated rejection (AMR), researchers found. Individuals found to carry the bacteria after ...

Referral for Transplantation The identification of poor prognostic features in patients with PAH should prompt a timely referral for assessment for lung transplantation. A major component of the ...

The study demonstrated that lung transplantation can be performed in candidates with advanced age and can provide life-extending benefits. Recipients aged 70 and above had more frequent ...

While debating the pros and cons of robotically assisted lung transplantation, Albert Jauregui, MD, PhD told attendees at the Annual Meeting and Scientific Sessions of the International Society ...

Bengaluru: About 10-30 per cent of all cases of lung cancer in India are found among people who have never smoked, with some Indian studies pegging this figure as high as 40 per cent. The ...

Source Reference: Tissot A, et al. "Increased delay to lung transplantation for women candidates: Gender-based disparity matters in the lung transplant trajectory" ERJ Open Res 2024; DOI: 10.1183 ...

Early infection caused extensive inflammation in many different body systems, noted Dr. Scott Scheinin, MD, director of lung transplantation for Mount Sinai Health System in New York City.